1. U.S. Food and Drug Administration Center for Drug Evaluation and Research.bioequivalence studies with pharmacokinetic endpoints for drugs submitted under an abbreviated new drug application. draft guidance for industry. Available from: (2021). Accessed January 27 2022.
2. International Guidelines for Bioequivalence of Locally Acting Orally Inhaled Drug Products: Similarities and Differences
3. Addressing the Regulatory and Scientific Challenges with Generic Orally Inhaled Drug Products
4. U.S. Food and Drug Administration.Draft guidance on beclomethasone dipropionate. Recommended May 2019. Available from: (2019). Accessed January 27 2022.
5. U.S. Food and Drug AdministrationComparative analyses and related comparative use human factors studies for a drug‐device combination product submitted in an ANDA: draft guidance for industry. Available from: (2017). Accessed January 27 2022.